These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 18757431)
1. CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis. Lui WO; Zeng L; Rehrmann V; Deshpande S; Tretiakova M; Kaplan EL; Leibiger I; Leibiger B; Enberg U; Höög A; Larsson C; Kroll TG Cancer Res; 2008 Sep; 68(17):7156-64. PubMed ID: 18757431 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera. Panagopoulos I; Möller E; Dahlén A; Isaksson M; Mandahl N; Vlamis-Gardikas A; Mertens F Genes Chromosomes Cancer; 2007 Feb; 46(2):181-91. PubMed ID: 17117415 [TBL] [Abstract][Full Text] [Related]
3. DNA-based polymerase chain reaction for detecting FUS-CREB3L2 in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Matsuyama A; Hisaoka M; Shimajiri S; Hashimoto H Diagn Mol Pathol; 2008 Dec; 17(4):237-40. PubMed ID: 18382348 [TBL] [Abstract][Full Text] [Related]
4. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195 [TBL] [Abstract][Full Text] [Related]
5. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the human CREB3L2 gene promoter. Panagopoulos I; Mertens F Oncol Rep; 2009 Mar; 21(3):615-24. PubMed ID: 19212619 [TBL] [Abstract][Full Text] [Related]
7. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951 [TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones inhibit REG Ialpha gene transcription in gastrointestinal cancer cells. Yamauchi A; Takahashi I; Takasawa S; Nata K; Noguchi N; Ikeda T; Yoshikawa T; Shervani NJ; Suzuki I; Uruno A; Unno M; Okamoto H; Sugawara A Biochem Biophys Res Commun; 2009 Feb; 379(3):743-8. PubMed ID: 19118520 [TBL] [Abstract][Full Text] [Related]
9. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells. Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499 [TBL] [Abstract][Full Text] [Related]
10. Expression pattern and preliminary functional analysis of human CREB4 gene. Gao YJ; Cao GT; Yin G; Wang X; Ji CN; Gu SH; Ni XH Yi Chuan Xue Bao; 2005 Sep; 32(9):898-902. PubMed ID: 16201231 [TBL] [Abstract][Full Text] [Related]
11. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Giordano TJ; Au AY; Kuick R; Thomas DG; Rhodes DR; Wilhelm KG; Vinco M; Misek DE; Sanders D; Zhu Z; Ciampi R; Hanash S; Chinnaiyan A; Clifton-Bligh RJ; Robinson BG; Nikiforov YE; Koenig RJ Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1983-93. PubMed ID: 16609007 [TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of olive flounder (Paralichthys olivaceus) peroxisome proliferator-activated receptor gamma. Cho HK; Kong HJ; Nam BH; Kim WJ; Noh JK; Lee JH; Kim YO; Cheong J Gen Comp Endocrinol; 2009 Sep; 163(3):251-8. PubMed ID: 19393656 [TBL] [Abstract][Full Text] [Related]
13. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo. Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620 [TBL] [Abstract][Full Text] [Related]
14. Identification of a truncated alternative splicing variant of human PPARgamma1 that exhibits dominant negative activity. Kim HJ; Woo IS; Kang ES; Eun SY; Kim HJ; Lee JH; Chang KC; Kim JH; Seo HG Biochem Biophys Res Commun; 2006 Sep; 347(3):698-706. PubMed ID: 16842753 [TBL] [Abstract][Full Text] [Related]
15. PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway. Kato Y; Ying H; Zhao L; Furuya F; Araki O; Willingham MC; Cheng SY Oncogene; 2006 May; 25(19):2736-47. PubMed ID: 16314832 [TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin and human thyroid cancer. Lin JD Clin Chim Acta; 2008 Feb; 388(1-2):15-21. PubMed ID: 18060877 [TBL] [Abstract][Full Text] [Related]
17. Hyalinizing spindle cell tumor with giant rosettes arising in the lung: report of a case with FUS-CREB3L2 fusion transcripts. Kim L; Yoon YH; Choi SJ; Han JY; Park IS; Kim JM; Chu YC; Kim YJ Pathol Int; 2007 Mar; 57(3):153-7. PubMed ID: 17295648 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067 [TBL] [Abstract][Full Text] [Related]
19. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161 [TBL] [Abstract][Full Text] [Related]